» Articles » PMID: 7546660

Influenza Virus Vectors

Overview
Journal Biologicals
Date 1995 Jun 1
PMID 7546660
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The establishment of reverse genetics methods to manipulate influenza virus genomes has allowed the generation of recombinant (transfectant) influenza viruses expressing foreign sequences. Strategies for the construction of influenza virus vectors include the insertion of foreign epitopes into influenza virus glycoproteins, the expression of polyproteins, and the rescue of bicistronic genes into infectious viruses. Influenza virus vectors have been obtained which express both B- and T-cell epitopes from different pathogens. These constructs have been shown to mount in immunized animals systemic and local antibody responses, and/or cytotoxic T-cell responses against the expressed epitope. The available evidence suggests that influenza virus vectors may be attractive candidates for the development of effective vaccines against different diseases.

Citing Articles

Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation.

Din G, Wu C, Tariq Z, Hasham K, Amjad M, Shen B Virol J. 2024; 21(1):196.

PMID: 39180083 PMC: 11344405. DOI: 10.1186/s12985-024-02433-8.


The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis.

Daian E Silva D, Guimaraes da Fonseca F Vaccines (Basel). 2021; 9(10).

PMID: 34696209 PMC: 8538930. DOI: 10.3390/vaccines9101101.


Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin.

Park B, Kim K, Kotomina T, Kim M, Kwon Y, Jeeva S Sci Rep. 2021; 11(1):4151.

PMID: 33603072 PMC: 7893060. DOI: 10.1038/s41598-021-83704-0.


Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus.

Jung Y, Lee Y, Kim K, Lee Y, Jeeva S, Park B Vaccines (Basel). 2020; 8(4).

PMID: 33271920 PMC: 7711863. DOI: 10.3390/vaccines8040716.


Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.

Lee Y, Hwang H, Kim M, Lee Y, Kim Y, Lee F Nanomedicine. 2015; 12(3):759-770.

PMID: 26656630 PMC: 4811744. DOI: 10.1016/j.nano.2015.11.007.